(±)trans-2, 5-bis-(3, 4, 5-Trimethoxyphenyl)-1, 3-dioxolane Catalog No.:M22691-C suggesting that targeting TGFβ signaling

suggesting that targeting TGFβ signaling pathway may be a potential strategy to inhibit MSC-induced stemness and chemoresistance

24 hours) increases the C6 cells viability significantly by concentration dependent manner

InChiKey: DKPTUMKZXQOJCX-DYXJTDGYSA-N

and antagonism of NPY Y1 and NPY Y5 receptors (NPYxR) is considered a potentially important anti-obesity drug target

(±)trans-2, 5-bis-(3, 4, 5-Trimethoxyphenyl)-1, 3-dioxolane Catalog No.:M22691-C suggesting that targeting TGFβ signaling()trans 2,5 bis (3,4,5 Trimethoxyphenyl) 1,3 dioxolane, also known as trans BTP Dioxolane, is a PAF receptor antagonist . Platelet activating factor (PAF), a phospholipid mediator of inflammation, is secreted by several cell types including arterial endothelial cells, and can activate polymorphonuclear leucocytes and monocytes via specific cell surface receptors. PAF also stimulates the production of active oxygen species by human monocyte derived